Archimedes Tech SPAC Partners II Announces Its SEC's Registration Statement On Form S-4 Declared Effective For Its Proposed Business Combination With Forge Nano

Archimedes Tech SPAC Partners II Merger Partner Forge Nano Signs Joint Development Agreement With Nanexa To Develop Scalable Pharmaceutical Manufacturing Capabilities For The PharmaShell Drug Delivery Platform

Under the agreement, Forge Nano and Nanexa will collaborate on the development of a large scale GMP-compliant ALD manufacturing equipment intended to support clinical development and potential future commercial-scale

Forge Nano, Merging With Archimedes Tech SPAC Partners II, Announces Expanded Agreement With Voltaiq To Deploy Battery Intelligence And AI Analytics Platform Across U.S. Battery Operations; Terms Not Disclosed

Archimedes Tech SPAC Partners II Co. Files Third Amendment To Registration Statement On Form S-4 With The SEC

Archimedes Tech SPAC Partners II Co. (NASDAQ:ATII), a publicly traded special purpose acquisition company ("ATII" or "Archimedes II"), today announced the filing with the U.S. Securities and Exchange